Silence Therapeutics plc SLN

$ 6.96 9.7%

Annual report 2023
added 12-21-2024

Silence Therapeutics plc Balance Sheet 2011-2024 | SLN

Annual Balance Sheet Silence Therapeutics plc

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-42.7 M	-39 M	-51.9 M	-16.9 M	-15.9 M	-8.91 M	-3.69 M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	179 K	446 K	137 K	341 K	287 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	51.3 M	15.5 M	-	-	-	-	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	76.9 M	25.2 M	3.83 M	2.66 M	1.61 M	1.12 M	2.01 M	1.72 M	959 K	1.26 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-184 M	-152 M	-134 M	-116 M	-116 M	-109 M	-103 M	-91.9 M	-82.9 M	-57.8 M
Total Assets	-	-	-	86 M	46.1 M	38.9 M	55 M	55.8 M	61.5 M	29.8 M	29.3 M	17.1 M	33.4 M
Cash and Cash Equivalents	54 M	54.8 M	73.5 M	27.4 M	13.5 M	21.5 M	-	-	-	-	-	-	-
Book Value	-	-	-	9.06 M	20.9 M	35.1 M	52.4 M	54.2 M	60.4 M	27.8 M	27.6 M	16.1 M	32.2 M
Total Shareholders Equity	-	-	-	9.06 M	20.9 M	35.1 M	-	-	-	-	-	-	-

All numbers in GBP currency

Quarterly Balance Sheet Silence Therapeutics plc

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	72.5 M	-	-	-	51.3 M	-	-	-	15.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-223 M	-	-	-	-184 M	-	-	-	-152 M	-	-	-	-134 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	73.5 M	-	-	-	27.4 M	-	-	-	13.5 M	-	-	-	21.5 M	-	-	-	42.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	8.53 M	-	-	-	9.06 M	-	-	-	20.9 M	-	-	-	35.1 M	-	-	-	52.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency